Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.S. Federal Trade Commission
Biotech
Pfizer finalizes Metsera buy after contentious Novo bidding war
The finished deal caps a whirlwind two weeks in which Novo Nordisk attempted to swoop in and snatch the startup from under Pfizer’s nose.
Darren Incorvaia
Nov 13, 2025 12:43pm
FTC tells Novo that Metsera offer may violate US merger law
Nov 5, 2025 4:26pm
FTC sues to block Surmodics acquisition over coating competition
Mar 7, 2025 11:00am
AbbVie CEO Gonzalez brushes off FTC concerns for Cerevel buy
Dec 7, 2023 11:26am
CooperSurgical calls off $875M Cook Medical deal amid FTC probe
Aug 3, 2023 10:57am
Boston Scientific nixes $230M M.I.Tech acquisition
May 25, 2023 12:59pm
